The expression level of the EGFR receptor in PDAC is about 30 to 90 percent, while erbB-2 expression is about 10 to 80 percent in pancreatic cancer tissue samples [12,13,14,15,16,17]. Here, ERBB2 is linked to familial pancreatic carcinoma.